Key result
TUDCA normalizes blood pressure and restores vascular and PVAT function in protein-restricted mice.
Why the study?
The mechanisms underlying vascular dysfunction after early-life protein restriction and effective therapeutic strategies remain poorly defined, and whether tauroursodeoxycholic acid (TUDCA) exerts vasculoprotective effects in this setting was unknown.
Does tauroursodeoxycholic acid (TUDCA) restore aortic and perivascular adipose tissue (PVAT) function and attenuate fibrosis in post-weaning protein-restricted mice?
Does tauroursodeoxycholic acid (TUDCA) restore aortic and perivascular adipose tissue (PVAT) function and attenuate fibrosis in post-weaning protein-restricted mice?
In a preclinical mouse model of post-weaning protein restriction, ER stress inhibition with TUDCA reversed male-specific hypertension, aortic endothelial and contractile dysfunction, PVAT remodeling, and vascular fibrosis.
Answers are grounded in this paper and cite their sources.
TUDCA may mitigate vascular effects of early protein restriction in mice; leaves open translation to human cardiovascular prevention.
Background Early-life protein restriction is a risk factor for cardiovascular disease, yet the mechanisms underlying vascular dysfunction and therapeutic strategies remain poorly defined. Tauroursodeoxycholic acid (TUDCA) is a bile acid that inhibits endoplasmic reticulum (ER) stress and has therapeutic potential in metabolic diseases. We hypothesized that TUDCA exerts vasculoprotective effects in the setting of post-weaning protein restriction. Methods Post-weaning male and female mice fed a normoprotein (14% protein) or protein-restricted (6% protein, isocaloric) diet for 105 days. In the last 15 days, mice received TUDCA (300 mg/kg/day) or vehicle. Vascular function was assessed in the thoracic aorta with or without perivascular adipose tissue (PVAT). mRNA expression and histological analyses were performed in aorta and PVAT. Results Long-term protein restriction resulted in endothelial dysfunction, vascular hypocontractility, and loss of the anticontractile effect of PVAT in males, but not females. These alterations were restored by TUDCA. In aorta, TUDCA normalized expression of eNOS and contractile phenotype-related genes α-actin, SM22α, Cav1.2 whereas, in the PVAT, TUDCA restored lipid content and expression of PRDM16, PPARγ, PGC1α, leptin, and OB-Rb in protein-restricted mice. TUDCA attenuated fibrosis and ER stress markers while increased the bile acid receptor FXR expression in both tissues. Similar to TUDCA, ER stress inhibition with 4-phenylbutyric acid restored vascular and PVAT function in protein-restricted male mice. Conclusions Post-weaning protein restriction induces vascular and PVAT dysfunction and fibrosis in males, associated with ER stress. TUDCA significantly attenuates these alterations, supporting its potential as a therapeutic strategy for vascular complications associated with early-life undernutrition.
No takes yet. Share an insight, caveat, or question.
Freitas et al. (2026) studied Post-weaning protein restriction / early-life malnutrition. Tauroursodeoxycholic acid (TUDCA) vs. Vehicle (PBS) was evaluated on Aortic vascular reactivity (endothelial relaxation and contractility), PVAT anticontractile function, and systolic blood pressure. TUDCA normalized blood pressure and restored aortic endothelial function, contractility, and PVAT anticontractile effects in protein-restricted male mice.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: